Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis
Topline data from FIBRONEERâ„¢-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change ...
Business Insider4d
Pliant Therapeutics Pauses Enrollment And Dosing In BEACON-IPF Trial, Stock In Freefall
BEACON-IPF is a phase IIb/III trial evaluating the company's lead drug candidate Bexotegrast in patients with idiopathic pulmonary fibrosis. On Friday (Feb.7, 2025), the company announced that it ...
pharmaphorum2d
ATS: Vicore, Endeavor therapies show promise in IPF
Two experimental therapies from Vicore Pharma and Endeavor BioMedicines that could provide new ways of treating idiopathic pulmonary fibrosis (IPF) have shown encouraging results in mid-stage ...
CNBC3d
11 best credit cards that offer preapproval in 2025
Visit americanexpress.com to learn more. Getting preapproved for a credit card doesn't guarantee you'll be approved, but it can give you a better idea of your approval odds with no hard inquiry.
inkbotdesign.com2d
Top 20 Fashion Logos: Best Designs in the Industry
Discover the Top 20 best Fashion Logos that define style in the industry! From iconic to innovative, explore how these logos captivate audiences! In fashion, logos are more than just symbols; they are ...